Inventor · disambiguated record
David Lawrence Firman Gray
Also filed as: GRAY DAVID L · GRAY DAVID LAWRENCE FIRMAN
21 granted patents·5 pending applications·89 citations·filing 2005–2024
94Inventor score
Files withPFIZER26
Top patents by PatentIndex Score
26 records- 0194US9107923B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Aug 18, 2015·11 cites·30 claims
- 0293US9527831B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2014·Granted Dec 27, 2016·13 cites·30 claims
- 0393US9139561B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Sep 22, 2015·8 cites·30 claims
- 0491US9822097B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2016·Granted Nov 21, 2017·6 cites·15 claims
- 0590US8822494B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2013·Granted Sep 2, 2014·12 cites·54 claims
- 0689US9688698B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jun 27, 2017·4 cites·20 claims
- 0789US2024317713A1Heteroaromatic compounds and their use as dopamine d1 ligandsPFIZER·Filed 2024·Application pending·0 cites
- 0887US9617275B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Apr 11, 2017·5 cites·18 claims
- 0987US9133190B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2014·Granted Sep 15, 2015·8 cites·60 claims
- 1086US10093655B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2017·Granted Oct 9, 2018·3 cites·20 claims
- 1186US9540352B2Substituted 1,7-naphthyridines as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jan 10, 2017·5 cites·26 claims
- 1284US10421744B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2018·Granted Sep 24, 2019·2 cites·20 claims
- 1382US9527843B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Dec 27, 2016·3 cites·14 claims
- 1479US9856263B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jan 2, 2018·2 cites·16 claims
- 1577US11964961B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 1674US11014909B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2020·Granted May 25, 2021·0 cites·22 claims
- 1774US10696658B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2019·Granted Jun 30, 2020·0 cites·13 claims
- 1873US7659394B2Substituted morpholine compounds for the treatment of central nervous system disordersPFIZER·Filed 2005·Granted Feb 9, 2010·4 cites·10 claims
- 1971US9868744B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jan 16, 2018·1 cites·14 claims
- 2071US9850232B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2016·Granted Dec 26, 2017·1 cites·25 claims
- 2166US9745317B2Heterocyclic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Aug 29, 2017·1 cites·22 claims
- 2262US2017165270A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2017·Application pending·0 cites
- 2362US2015291625A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2013·Application pending·0 cites
- 2460US2018200253A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2018·Application pending·0 cites
- 2557US2018346477A1Heteroaromatic compounds and their use as dopamine d1 ligandsPFIZER·Filed 2018·Application pending·0 cites
- 2656US10077272B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2017·Granted Sep 18, 2018·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when David Lawrence Firman Gray files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →